Compare OCTV & VCRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | OCTV | VCRE |
|---|---|---|
| Founded | N/A | N/A |
| Country | United States | Sweden |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | |
| Sector | Technology | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.8B | 3.3B |
| IPO Year | N/A | N/A |
| Metric | OCTV | VCRE |
|---|---|---|
| Price | $16.99 | $11.06 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 849.5K | 3.0K |
| Earning Date | N/A | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $15.41 | $11.00 |
| 52 Week High | $18.38 | $12.85 |
| Indicator | OCTV | VCRE |
|---|---|---|
| Relative Strength Index (RSI) | 58.45 | 22.97 |
| Support Level | $16.56 | $11.00 |
| Resistance Level | $17.36 | $12.85 |
| Average True Range (ATR) | 0.45 | 0.51 |
| MACD | -0.09 | -0.09 |
| Stochastic Oscillator | 79.49 | 28.10 |
Vicore Pharma Holding AB is a clinical-stage biopharmaceutical company developing a new class of disease-modifying therapies for respiratory and fibrotic diseases, including idiopathic pulmonary fibrosis (IPF). Its main program, buloxibutid, is an oral angiotensin II type 2 receptor agonist that has received Orphan Drug and Fast Track designation from the U.S. Food and Drug Administration and is currently being evaluated in the 52-week Phase 2b ASPIRE trial in IPF. Currently, Vicore is operating mainly in Sweden.